Lodestar Bio

Lodestar will address challenges faced by families of children with rare diseases who are seeking a diagnosis. Our solution is a two-sided marketplace for rare disease genomic insights. On one side, we offer children who have a rare disease—and an inconclusive whole genome assay—another chance at a diagnosis. A majority of families who order a whole genome test do not receive their much needed diagnosis and are rarely provided with clear followup options. On the other side of the market, we use the genomic data we collect to identify orphan drug leads, and partner with biopharma to create personalized medicines. A timely and accurate diagnosis transforms the lives of children with rare diseases. Lodestar’s mission is to create a world in which every child can expect a diagnosis.